Skip to main content
Log in

FP 21399

  • Section 2: HIV Fusion Inhibitor
  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ono M, Wada Y, Wu Y, et al. FP-21399 blocks HIV envelope protein-mediated membrane fusion and concentrates in lymph nodes. Nat Biotechnol 1997 Apr; 15: 343–8

    Article  PubMed  CAS  Google Scholar 

  2. Zhang JL, Choe H, Dezube BJ, et al. The bis-azo compound FP-21399 inhibits HIV-1 replication by preventing viral entry. Virology 1998 May 10; 244: 530–41

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

FP 21399. Drugs R&D 2, 343–344 (1999). https://doi.org/10.2165/00126839-199902050-00014

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199902050-00014

Keywords

Navigation